A clinical trial has begun which will use stem cell transplants to grow a new immune system for people with untreatable Crohn’s disease – a painful and chronic intestinal disease which affects at least 115,000 people in the UK.
The study, led by Queen Mary University of London and Barts Health NHS Trust, is funded with £2m from a Medical Research Council and National Institute for Health Research partnership, and will be recruiting patients from centres in Cambridge, Edinburgh, Liverpool, London, Nottingham, Oxford and Sheffield. The trial is coordinated through the Clinical Trials Unit at the University of Sheffield.
Crohn’s disease is a long-term condition that causes inflammation of the lining of the digestive system, and results in diarrhoea, abdominal pain, extreme tiredness and other symptoms that significantly affect quality of life.
Current treatments include drugs to reduce inflammation but these have varying results, and surgery is often needed to remove the affected part of the bowel. In extreme cases, after multiple operations over the years, patients may require a final operation to divert the bowel from the anus to an opening in the stomach, called a stoma, where stools are collected in a pouch.
‘We might be able to radically alter the course of the disease’
Chief investigator Professor James Lindsay from Queen Mary’s Blizard Institute and a consultant at Barts Health NHS Trust said: “Despite the introduction of new drugs, there are still many patients who don’t respond, or gradually lose response, to all available treatments. Although surgery with the formation of a stoma may be an option that allows patients to return to normal daily activities, it is not suitable in some and others may not want to consider this approach.
“We’re hoping that by completely resetting the patient’s immune system through a stem cell transplant, we might be able to radically alter the course of the disease. While it may not be a cure, it may allow some patients to finally respond to drugs which previously did not work.”
Helen Bartlett, a Crohn’s disease patient who had stem cell therapy at John Radcliffe Hospital, Oxford, said: “Living with Crohn’s is a daily struggle. You go to the toilet so often, you bleed a lot and it’s incredibly tiring. You also always need to be careful about where you go. I’ve had to get off trains before because there’s been no toilet, and I needed to go there and then.
“I’ve been in and out of hospital for the last twenty years, operation after operation, drug after drug, to try to beat this disease. It’s frustrating, it’s depressing and you just feel so low.
“When offered the stem cell transplant, it was a complete no brainer as I didn’t want to go through yet more failed operations. I cannot describe how much better I feel since the treatment. I still have problems and I’m always going to have problems, but I’m not in that constant pain.”
Giving patients a new immune system
The Latest on: Crohn’s disease
via Google News
The Latest on: Crohn’s disease
- Inflammatory Bowel Disease Tied to Increased Dementia Riskon July 2, 2020 at 8:57 am
Those with Crohn’s disease or ulcerative colitis had higher rates of Alzheimer’s disease and other forms of dementia.
- 5 Smart Diet Changes to Optimize Gut Health and Manage Crohn’s Symptomson July 1, 2020 at 3:33 pm
Crohn’s varies in severity from mild to debilitating—and while it tends to affect your small intestine and colon the most, the disease can also impact any part of your gastrointestinal (GI) tract, ...
- Celsius Therapeutics Signs Research Agreements with Leading Academic Centers to Develop Insights into Inflammatory Bowel Disease Biologyon July 1, 2020 at 5:30 am
Celsius Therapeutics, a company focused on bringing precision medicine to patients with autoimmunity, cancer and other complex diseases, today announced the signing of three collaboration agreements ...
- Magician Dynamo walks his dogs after being tested in hospital following a Crohn's disease flare-up weeks after recovering from coronaviruson July 1, 2020 at 5:16 am
Dynamo stepped out with his dogs on Monday, weeks after telling fans he had gone to hospital due to a Crohn's disease flare-up.
- Impact of immune-mediated diseases in inflammatory bowel disease and implications in therapeutic approachon July 1, 2020 at 2:27 am
Inflammatory bowel diseases (IBD) belong to the group of immune-mediated diseases (IMIDs). The effect of IMIDs in the prognosis in IBD is nowadays unknown. To describe ...
- CrohnaEUR(TM)s Disease Therapeutics Market By Current Industry Status, Growth Opportunities, Top Key Players, Target Audience And Forecast To 2027on June 30, 2020 at 8:27 am
The global Crohn's disease market is estimated to grow at a significant CAGR of 4.2% during the forecast period. Crohn's disease inflammation spreads into the layers of affected bowel tissues. Crohn's ...
- Irritable bowel disease heightens the risk of dementiaon June 28, 2020 at 3:46 pm
Scientists have long explored the link between the gut and the brain. Now, a new study shows that older adults with chronic inflammation of the digestive tract may develop dementia more than seven ...
- Inflammatory Bowel Disease Tied to a Doubling of Dementia Riskon June 26, 2020 at 11:28 am
Increased dementia risk and earlier onset of dementia in patients with IBD support a role for the gut–brain axis and chronic inflammation in progressive neurocognitive decline.
- An Integrated Genomic and Transcriptomic Analysis Reveals Candidates of Susceptibility Genes for Crohn’s Disease in Japanese Populationson June 24, 2020 at 2:15 am
Inflammatory bowel disease (IBD) is a term for two conditions: Crohn’s disease (CD) and ulcerative colitis. IBD is a multifactorial disease where development of the disease involves both hereditary ...
via Bing News